348 related articles for article (PubMed ID: 28535419)
1. Comparison of the efficacy of fixed-dose enoxaparin and adjusted-dose unfractionated heparin in patients with cerebral venous thrombosis.
Korathanakhun P; Petpichetchian C; Petpichetchian W; Sathirapanya P
Clin Neurol Neurosurg; 2017 Aug; 159():50-54. PubMed ID: 28535419
[TBL] [Abstract][Full Text] [Related]
2. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis.
Lurkin A; Derex L; Fambrini A; Bertoletti L; Epinat M; Mismetti P; Dargaud Y
Cerebrovasc Dis; 2019; 48(1-2):32-37. PubMed ID: 31480062
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
4. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
[TBL] [Abstract][Full Text] [Related]
5. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
[TBL] [Abstract][Full Text] [Related]
6. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
Weiss A; Brose S; Ploetze K; Matschke K
Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in thrombo-prophylaxis.
Ishi SV; Lakshmi M; Kakde ST; Sabnis KC; Jagannati M; Girish TS; Jeyaseelan L; Cherian AM
J Assoc Physicians India; 2013 Dec; 61(12):882-6. PubMed ID: 24968543
[TBL] [Abstract][Full Text] [Related]
8. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis.
Coutinho JM; Ferro JM; Canhão P; Barinagarrementeria F; Bousser MG; Stam J;
Stroke; 2010 Nov; 41(11):2575-80. PubMed ID: 20930161
[TBL] [Abstract][Full Text] [Related]
9. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients.
Arnold JD; Dart BW; Barker DE; Maxwell RA; Burkholder HC; Mejia VA; Smith PW; Longley JM
Am Surg; 2010 Jun; 76(6):563-70. PubMed ID: 20583509
[TBL] [Abstract][Full Text] [Related]
10. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.
Riess H; Koppenhagen K; Tolle A; Kemkes-Matthes B; Gräve M; Patek F; Drexler M; Siemens HJ; Harenberg J; Weidinger G; Brom J; Haas S;
Thromb Haemost; 2003 Aug; 90(2):252-9. PubMed ID: 12888872
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
De A; Roy P; Garg VK; Pandey NK
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
[TBL] [Abstract][Full Text] [Related]
12. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry.
Auffret V; Leurent G; Boulmier D; Bedossa M; Zabalawi A; Hacot JP; Coudert I; Filippi E; Castellant P; Rialan A; Rouault G; Druelles P; Boulanger B; Treuil J; Avez B; Le Guellec M; Gilard M; Le Breton H
Arch Cardiovasc Dis; 2016 Dec; 109(12):696-707. PubMed ID: 27818120
[TBL] [Abstract][Full Text] [Related]
14. Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.
Chong BH; Brighton TA; Baker RI; Thurlow P; Lee CH;
J Thromb Thrombolysis; 2005 Jun; 19(3):173-81. PubMed ID: 16082604
[TBL] [Abstract][Full Text] [Related]
15. Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and literature review.
Alet M; Ciardi C; Alemán A; Bandeo L; Bonardo P; Cea C; Cirio J; Cossio J; Cuculic M; Esnaola MM; García-Pérez F; Giner F; Gómez-Schneider M; Isaac C; Lepera S; Martínez C; Martínez-Lorenzín R; Montes M; Orzuza G; Persi G; Povedano G; Pujol-Lereis V; Quiroga-Narváez J; Romano M; Sabio R; Viglione J; Zurrú MC; Saposnik G;
J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105145. PubMed ID: 32912503
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial.
Pineo G; Lin J; Stern L; Subrahmanian T; Annemans L
J Hosp Med; 2012 Mar; 7(3):176-82. PubMed ID: 22058011
[TBL] [Abstract][Full Text] [Related]
17. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
19. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.
Yaghi S; Shu L; Bakradze E; Salehi Omran S; Giles JA; Amar JY; Henninger N; Elnazeir M; Liberman AL; Moncrieffe K; Lu J; Sharma R; Cheng Y; Zubair AS; Simpkins AN; Li GT; Kung JC; Perez D; Heldner M; Scutelnic A; Seiffge D; Siepen B; Rothstein A; Khazaal O; Do D; Kasab SA; Rahman LA; Mistry EA; Kerrigan D; Lafever H; Nguyen TN; Klein P; Aparicio H; Frontera J; Kuohn L; Agarwal S; Stretz C; Kala N; El Jamal S; Chang A; Cutting S; Xiao H; de Havenon A; Muddasani V; Wu T; Wilson D; Nouh A; Asad SD; Qureshi A; Moore J; Khatri P; Aziz Y; Casteigne B; Khan M; Cheng Y; Mac Grory B; Weiss M; Ryan D; Vedovati MC; Paciaroni M; Siegler JE; Kamen S; Yu S; Leon Guerrero CR; Atallah E; De Marchis GM; Brehm A; Dittrich T; Psychogios M; Alvarado-Dyer R; Kass-Hout T; Prabhakaran S; Honda T; Liebeskind DS; Furie K
Stroke; 2022 Mar; 53(3):728-738. PubMed ID: 35143325
[TBL] [Abstract][Full Text] [Related]
20. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study.
Hillbom M; Erilä T; Sotaniemi K; Tatlisumak T; Sarna S; Kaste M
Acta Neurol Scand; 2002 Aug; 106(2):84-92. PubMed ID: 12100367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
